Cargando…

Associations of Plasma Bioactive Adrenomedullin Levels with Cardiovascular Risk Factors in BRCA1/2 Mutation Carriers

Background Cardiovascular disease (CVD) is an important cause of morbidity and mortality in breast cancer survivors. Effective screening modalities to identify CVD risk are lacking in this population. Adrenomedullin (ADM) has been suggested as a biomarker for subclinical cardiac dysfunction in the g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lammert, Jacqueline, Basrai, Maryam, Struck, Joachim, Hartmann, Oliver, Engel, Christoph, Bischoff, Stephan C., Berling-Ernst, Anika, Halle, Martin, Kiechle, Marion, Grill, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315398/ https://www.ncbi.nlm.nih.gov/pubmed/35903716 http://dx.doi.org/10.1055/a-1811-2164

Ejemplares similares

Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle-intervention in germline BRCA1/2 gene mutation carriers
por: Grill, Sabine, et al.
Publicado: (2021)

Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers – an interventional randomized controlled multicenter trial (LIBRE-1)
por: Kiechle, Marion, et al.
Publicado: (2017)

Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1
por: Neirich, Leonie, et al.
Publicado: (2021)

How Does Dietary Intake Relate to Dispositional Optimism and Health-Related Quality of Life in Germline BRCA1/2 Mutation Carriers?
por: Esser, Anne, et al.
Publicado: (2023)

Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial
por: Kiechle, Marion, et al.
Publicado: (2016)

Predictors of cardiopulmonary fitness in cancer-affected and -unaffected women with a pathogenic germline variant in the genes BRCA1/2 (LIBRE-1)
por: Berling-Ernst, A., et al.
Publicado: (2022)

Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study)
por: Kiechle, Marion, et al.
Publicado: (2016)

Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
por: Molvin, John, et al.
Publicado: (2019)

Omega-3 polyunsaturated fatty acids improve intestinal barrier integrity—albeit to a lesser degree than short-chain fatty acids: an exploratory analysis of the randomized controlled LIBRE trial
por: Seethaler, Benjamin, et al.
Publicado: (2023)

Bioactive adrenomedullin for assessment of venous congestion in heart failure
por: Egerstedt, Anna, et al.
Publicado: (2022)

Increased concentrations of bioactive adrenomedullin subsequently to angiotensin‐receptor/neprilysin‐inhibitor treatment in chronic systolic heart failure
por: Arfsten, Henrike, et al.
Publicado: (2020)

Added value of serial bio-adrenomedullin measurement in addition to lactate for the prognosis of septic patients admitted to ICU
por: Blet, Alice, et al.
Publicado: (2020)

Circulating Biologically Active Adrenomedullin Predicts Organ Failure and Mortality in Sepsis
por: Kim, Hanah, et al.
Publicado: (2019)

Plasma bioactive adrenomedullin predicts outcome after acute stroke in early rehabilitation
por: Shafieesabet, Azadeh, et al.
Publicado: (2023)

Adrenomedullin in heart failure: pathophysiology and therapeutic application
por: Voors, Adriaan A., et al.
Publicado: (2018)

Validation of the German version of the Mediterranean Diet Adherence Screener (MEDAS) questionnaire
por: Hebestreit, Katrin, et al.
Publicado: (2017)

Adrenomedullin in plasma of surgical ICU-patients with sepsis - a pilot study
por: Simon, T-P, et al.
Publicado: (2015)

Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study
por: Christ-Crain, Mirjam, et al.
Publicado: (2005)

Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis
por: Marino, Rossella, et al.
Publicado: (2014)

Epitope specificity of anti-Adrenomedullin antibodies determines efficacy of mortality reduction in a cecal ligation and puncture mouse model
por: Struck, Joachim, et al.
Publicado: (2013)

Circulating Precursor Levels of Endothelin-1 and Adrenomedullin, Two Endothelium-Derived, Counteracting Substances, in Sepsis
por: Schuetz, Philipp, et al.
Publicado: (2007)

Bioactive adrenomedullin a prognostic biomarker in patients with mild to moderate dyspnea at the emergency department: an observational study
por: Bronton, Kevin, et al.
Publicado: (2021)

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
por: Christ-Crain, Mirjam, et al.
Publicado: (2006)

Proenkephalin A and bioactive adrenomedullin are useful for risk prognostication in cardiac surgery
por: Hill, Aileen, et al.
Publicado: (2023)

Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial
por: Takagi, Koji, et al.
Publicado: (2021)

Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness
por: Lundberg, Oscar H. M., et al.
Publicado: (2020)

Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study
por: Mebazaa, Alexandre, et al.
Publicado: (2018)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
por: Geven, Christopher, et al.
Publicado: (2018)

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study
por: Rhiem, Kerstin, et al.
Publicado: (2012)

Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3
por: van Lier, D., et al.
Publicado: (2020)

Activity of the adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failure
por: Kozhuharov, Nikola, et al.
Publicado: (2021)

Adrenomedullin and tumour angiogenesis
por: Nikitenko, L L, et al.
Publicado: (2006)

Adrenomedullin and tumour microenvironment
por: Larráyoz, Ignacio M, et al.
Publicado: (2014)

Adrenomedullin and cardiovascular diseases
por: Wong, Hoi Kin, et al.
Publicado: (2012)

Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial
por: van Lier, Dirk, et al.
Publicado: (2022)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

The Association of Mid-Regional Pro-Adrenomedullin and Mid-Regional Pro-Atrial Natriuretic Peptide with Mortality in an Incident Dialysis Cohort
por: Gouya, Ghazaleh, et al.
Publicado: (2011)

Management of the asymptomatic BRCA mutation carrier
por: Teller, Paige, et al.
Publicado: (2010)

Cancer risks among BRCA1 and BRCA2 mutation carriers
por: Levy-Lahad, E, et al.
Publicado: (2007)

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
por: McKinley, Joanne M, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_5mvgulemdcftqkgq6sb8q0eagg